Pharma News
Cabiralizumab by Bristol-Myers Squibb for Melanoma: Likelihood of Approval
Cabiralizumab is under clinical development by Bristol-Myers Squibb and currently in Phase I for Melanoma.
Source link
#Cabiralizumab #BristolMyers #Squibb #Melanoma #Likelihood #Approval
